GE HealthCare Acquires Remaining Stake in Nihon Medi-Physics (NMP)

March 31, 2025

GE HealthCare has completed the acquisition of Sumitomo Chemical's remaining 50% stake in Nihon Medi-Physics (NMP), giving GE HealthCare full ownership. The deal brings the Tokyo-based radiopharmaceutical manufacturer into GE HealthCare's Pharmaceutical Diagnostics segment (Kevin O'Neill to lead NMP) to expand its footprint and patient access to molecular imaging agents in Japan and the broader Asian market.

Buyers
GE HealthCare Technologies Inc.
Targets
Nihon Medi-Physics Co., Ltd.
Sellers
Sumitomo Chemical
Location
Tokyo, Japan
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.